🤔Can we get to one shot and you're done TPT?
Bedaquiline looks promising in mouse model. Now Phase 1 trial! More drugs in development!
🤔Can we get to one shot and you're done TPT?
Bedaquiline looks promising in mouse model. Now Phase 1 trial! More drugs in development!
-Overall, sensi (90.2%) but suboptimal spec (73.9%) , subgroups below.
- With good spec. could it be used as a near POC for TPT? Maybe, but would need to compare cost-effectiveness to other tools including CRP.
-Overall, sensi (90.2%) but suboptimal spec (73.9%) , subgroups below.
- With good spec. could it be used as a near POC for TPT? Maybe, but would need to compare cost-effectiveness to other tools including CRP.
📍TB tx trials should consider PROs and long term lung outcomes
📍Data needed on prevention and treatment.
🔬Will host-directed therapies will mitigate the damage? early data on NAC, doxy
📍TB tx trials should consider PROs and long term lung outcomes
📍Data needed on prevention and treatment.
🔬Will host-directed therapies will mitigate the damage? early data on NAC, doxy
❌ NO for daily DTG with 1HP in pregnancy, but 3HP is a possibility (troughs above goal). PK sampling of pregnant women taking daily DTG and 3HP is underway!
❌ NO for daily DTG with 1HP in pregnancy, but 3HP is a possibility (troughs above goal). PK sampling of pregnant women taking daily DTG and 3HP is underway!
Primary PK outcome: ✅ BID DTG levels therapeutic with both 1HP and 3HP. 2 women did not have therapeutic levels, due to adherence.
Primary PK outcome: ✅ BID DTG levels therapeutic with both 1HP and 3HP. 2 women did not have therapeutic levels, due to adherence.
Neel Gandhi- Universal WGS study in South Africa among people with XDR TB show casual contact (residential proximity or shared clinic) is the epi link for ~50% of clustered participants, close contacts <10%. Comm.-based approaches needed to interrupt transmission